Latest Shareholder Meeting News

Page 7 of 42
Cambium Bio has locked in a A$2.4 million strategic investment from Zheng Yang Biomedical Technology, reinforcing its push into pivotal Phase 3 trials for its dry eye disease treatment.
Ada Torres
Ada Torres
20 Jan 2026
Askari Metals has responded to an ASX query regarding an inadvertent breach of Listing Rule 10.11 after issuing securities to a related party without prior shareholder approval during a recent rights issue. The company outlines the circumstances and its planned remedial actions.
Maxwell Dee
Maxwell Dee
16 Jan 2026
Proteomics International Laboratories has appointed David Morris as CEO and Managing Director, marking a strategic shift towards commercialising its Promarker® diagnostic technology. Morris brings extensive global healthcare leadership experience to lead the company’s next growth phase.
Ada Torres
Ada Torres
14 Jan 2026
Apiam Animal Health has secured Foreign Investment Review Board approval for its acquisition by Adamantem Capital, paving the way for a crucial shareholder vote in February.
Ada Torres
Ada Torres
12 Jan 2026
Augustus Minerals has addressed ASX concerns over its recent appointment and election of a new director, clarifying compliance with listing rules despite timing challenges.
Maxwell Dee
Maxwell Dee
7 Jan 2026
I Synergy Group Limited has announced a planned 5-for-1 consolidation of its ordinary shares and options, pending shareholder approval. The move aims to reduce the number of securities on issue, with trading of consolidated shares set to begin in early February.
Claire Turing
Claire Turing
2 Jan 2026
AVA Risk Group has locked in a strategic investment of up to A$12.6 million from US-based Hale Capital, aiming to boost its footprint in the lucrative US critical infrastructure market. The deal includes convertible notes and warrants priced at an 81% premium, alongside a new board appointment.
Sophie Babbage
Sophie Babbage
31 Dec 2025
Forrestania Resources has formalised its acquisition of the Lake Johnston Project from Poseidon Nickel, marking a pivotal move towards near-term gold production with key infrastructure and contractor engagements.
Maxwell Dee
Maxwell Dee
31 Dec 2025
Medallion Metals secures ASX waiver allowing its discounted Share Purchase Plan to proceed without shareholder approval, enabling retail investors to buy shares at the same price as institutions.
Maxwell Dee
Maxwell Dee
29 Dec 2025
Native Mineral Resources Holdings has locked in a $3 million convertible note raising from Lind Global Fund III LP, with the option to access up to $10 million. The funding aims to bolster working capital and support growth in the Charters Tower region.
Maxwell Dee
Maxwell Dee
24 Dec 2025
Corella Resources has completed the first tranche of a $1 million share placement, issuing over 142 million shares at $0.0035 each. The second tranche and attached options await shareholder approval in early 2026.
Maxwell Dee
Maxwell Dee
23 Dec 2025
Pure Resources has completed a $1.7 million placement to fund its Garnet Hills Garnet and Graphite Project, with options to be issued pending shareholder approval.
Maxwell Dee
Maxwell Dee
23 Dec 2025